Extracellular adenosine has been implicated in adaptation to hypoxia and previous studies demonstrated a central role in vascular responses. Here, we examined the contribution of individual adenosine receptors (A1AR/A2AAR/A2BAR/A3AR) to vascular leak induced by hypoxia. Initial profiling studies revealed that siRNAmediated repression of the A2BAR selectively increased endothelial leak in response to hypoxia in vitro. In parallel, vascular permeability was significantly increased in vascular organs of A2BAR -/--mice subjected to ambient hypoxia (8% oxygen, 4h; e.g. lung: 2.1±0.12-fold increase). By contrast, hypoxia-induced vascular leak was not accentuated in A1AR -/--, A2AAR -/--, or A3AR -/--deficient mice, suggesting a degree of specificity for the A2BAR. Further studies in wild type mice revealed that the selective A2BAR antagonist PSB1115 resulted in profound increases in hypoxia-associated vascular leakage while A2BAR agonist (BAY60-6583) treatment was associated with almost complete reversal of hypoxia-induced vascular leakage (e.g. lung: 2.0±0.21-fold reduction). Studies in bone marrow chimeric A2BAR mice suggested a predominant role of vascular A2BARs in this response, while hypoxia-associated increases in tissue neutrophils were, at least in part, mediated by A2BAR expressing hematopoietic cells. Taken together, these studies provid e pharmacological and genetic evidence for vascular A2BAR signaling as central control point of hypoxia-associated vascular leak.
Introduction Introduction
Previous studies have implicated extracellular nucleotide metabolites, predominantly adenosine, as triggers of endogenous protective mechanisms in a number of acute injury models. 1-5 Extracellular adenosine is derived primarily through phosphohydrolysis of adenosine 5'-monophosphate (AMP). Ecto-5'-nucleotidase (CD73), a ubiquitously expressed ectoenzyme, is the pace-maker of this reaction. 6 Studies on the role of CD73 in tissue-injury showed that cd73 -/-mice develop profound vascular leakage and pulmonary edema upon hypoxia exposure. 6 Once generated into the extracellular space, adenosine can signal through any of four G-protein coupled adenosine-receptors (A1AR/A2AAR/A2BAR/A3AR). All of these receptors are expressed on vascular endothelia 4 and have been implicated in tissue-protection in different models of injury. Given that activation of ARs can lead to an elevation of intracellular cAMP, and that elevated cAMP in endothelia promotes barrier function, we considered the possibility of endothelial AR-signaling to regulate vascular permeability. In contrast to previous studies that found tissue protection during hypoxia or inflammation through signaling pathways involving the A2AAR, the present studies conclude that the A2BAR is central to the control of vascular leak in hypoxia.
Discussion Discussion
Adenosine exerts autocrine and paracrine actions on most cell types. Adverse conditions like hypoxia or ischemia result in the elevation of extracellular adenosine, 2,7-10 which has beneficial consequences including ischemic preconditioning 2, 7, 8, [10] [11] [12] and promotion of endothelial barrier function. 3, 4, 6 In this study, our goal was to identify the specific adenosine receptor responsible for the maintenance of vascular barrier function during normoxia or hypoxia. Our results point towards a pivotal role of the A2BAR in attenuating hypoxia-induced increases in vascular leak. In contrast, mice gene-targeted for other ARs failed to show an influence on vascular barrier function during hypoxia, providing some degree of specificity for the A2BAR. Moreover, in vivo studies of A2BAR bone marrow chimeric mice suggest an important contribution of vascular A2BARs in attenuating vascular leakage during hypoxia. In contrast, attenuation of hypoxia-associated increases in tissue neutrophil numbers appeared to depend largely on hematopoietic cell A2BAR signaling. A2BAR+/+→A2BAR-/-) were treated with the selective A2BAR agonist (BAY 60-6583, 80µg/kg i.p.) or an equal volume of PBS 30 min prior to intravenous Evans blue dye (0.2 ml of 0.5% in PBS) and exposed to room air or normobaric hypoxia (8% O2 , 92% N2 ) for 4h. Animals were sacrificed and the heart (Ht), colon (Co), kidney (Kd), lung (Lg), spleen (Sp), brain (Br), muscle (Mu) and liver (Lv) were harvested. Organ Evans blue dye concentrations were quantified following formamide extraction (55°C for 2h) as described in Materials and Methods. Data are expressed as mean ± SD Evans blue OD/50mg wet tissue (n=6 animals/condition). (A: *P < 0.05, compared with normoxia; **P < 0.05, compared with -BAY 60-6583 control; and #P < 0.05, compared with -BAY 60-6583 control and normoxia; B: *P < 0.05, compared with normoxia). In other experiments, mice were injected with intravenous Evans blue dye (0.2 ml of 0.5% in PBS per mouse) after PBS115 or vehicle treatment and exposed to room air or to normobaric hypoxia (8% O2 , 92% N2 ) for 4h. Animals were sacrificed and the heart (Ht), colon (Co), kidney (Kd), lung (Lg), spleen (Sp), brain (Br), muscle (Mu) and liver were harvested. Organ Evans blue dye concentrations were quantified as described in Materials and Methods. Data are expressed as mean ± SD Evans blue OD/50mg wet tissue; n=6 animals/condition (*P < 0.05, compared with normoxia; **P < 0.05, compared with normoxic -PSB1115 controls; and #P < 0.05, compared with normoxia and -PSB115 controls). (C) Age-, weight-and gender-matched wild type mice were administered a selective A2BAR agonist (BAY 60-6583, 80µg/kg.) or an equal volume of PBS and lung water content was measured. In other experiments, mice were injected with intravenous Evans blue dye (0.2 ml of 0.5% in PBS per mouse) after BAY 60-6583 or vehicle treatment and exposed to room air or to normobaric hypoxia (8% O2 , 92% N2 ) for 4h. Data are expressed as mean ± SD Evans blue OD/50mg wet tissue; n= 6 animals/condition (*P < 0.05, compared with normoxia; **P < 0.05, compared with -BAY 60-6583 normoxic controls and #P < 0.01, compared with -BAY 60-6583 hypoxic controls). 
Results

A2BAR-/-→A2BAR-/-; B: A2BAR-/-→A2BAR+/+ and A2BAR+/+→A2BAR-/-)
were administered intravenous Evans blue dye (0.2 ml of 0.5% in PBS) and exposed to room air or normobaric hypoxia (8% O2 , 92% N2 ) for 4h. Animals were sacrificed and the heart (Ht), colon (Co), kidney (Kd), lung (Lg), spleen (Sp), brain (Br), muscle (Mu) and liver were harvested. Organ Evans blue concentrations were quantified as described in Materials and Methods. Data are expressed as mean ± SD Evans blue OD/50mg wet tissue (n=6 animals/condition). (A: *P < 0.05, compared with normoxia; **P < 0.05, compared with A2BAR+/+→A2BAR+/+ bone marrow chimeric mice; and #P < 0.05, compared with A2BAR+/+→A2BAR+/+ bone marrow chimeric mice and normoxia. B: *P < 0.05, compared with normoxia; **P < 0.05, compared with A2BAR-/-→A2BAR+/+ bone marrow chimeric mice; and #P < 0.05, compared with A2BAR-/-→A2BAR+/+ bone marrow chimeric mice and normoxia). Wild type mice were subjected to normoxia or 4h of ambient hypoxia (8% oxygen). Whole lungs were fixed with 10% formalin at total lung capacity. Lungs were stained with antibody for the A2BAR. Normal goat IgG was used in controls at identical concentration and staining conditions as the target primary Ab (arrow marks vascular, asterisk alveolar structures). 
